| Name | N-Cycloheptyl-2-[(1-methyl-4,5-dihydro-1H-imidazol-2-yl)sulfanyl]-2-phenylacetamide |
|---|---|
| Synonyms |
N-Cyclohtyl-2-((1-methyl-4,5-dihydro-1H-imidazol-2-yl)thio)-2-phenylacetamide
Benzeneacetamide, N-cyclohtyl-α-[(4,5-dihydro-1-methyl-1H-imidazol-2-yl)thio] Apostain-1 Apostatin-1 ,S9705 Apostatin 1,TRADD,Apostatin-1,Beclin1,RIPK,Autophagy,SH-SY5Y,Rector-interacting protein kinases,Apoptosis,Apostatin1,HT-29,Jurkat cells,RIP kinase,inhibit,beclin 1,Inhibitor,Atg6,Apt1,Apt 1,Necroptosis,inflammatory responses,HeLa,RIPK1 N-Cyclohtyl-2-[(1-methyl-4,5-dihydro-1H-imidazol-2-yl)sulfanyl]-2-phenylacetamide Apostatin-1, 10 mM in DMSO |
| Description | Apostatin-1 (Apt-1) is a potent TRADD inhibitor. Apostatin-1 can bind with TRADD-N (KD=2.17 μM), disrupting its binding to both TRADD-C and TRAF2. Apostatin-1 modulates the ubiquitination of RIPK1 and beclin 1. Apostatin-1 blocks apoptosis and restores cellular homeostasis by activating autophagy in cells with accumulated mutant tau, α-synuclein, or huntingtin[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Apostatin-1 inhibits Velcade (bortezomib)-induced apoptosis and RIPK1-dependent apoptosis (RDA) and necroptosis, with an IC50 of 0.97 μM[1]. Apostatin-1 (10 μM, 6 h) effectively induces autophagy and the degradation of long-lived proteins[1]. Western Blot Analysis[1] Cell Line: SH-SY5Y, HeLa, HT-29, and Jurkat cells Concentration: 10 μM Incubation Time: 6 h Result: Effectively induced autophagy by LC3 II induction and p62 reduction. |
| In Vivo | Apostatin-1 (20 mg/kg, IP, once) inhibits inflammatory responses, and increases survival of systemic inflammation mouse model[1]. Animal Model: Wild-type mice (n = 10, male, 8 weeks of age, systemic inflammation mouse model)[1] Dosage: 20 mg/kg Administration: IP, once Result: Reduced expression of the TNF-induced inflammatory target gene products, NOS and COXII27, and of inflammatory cytokines in cells stimulated with pathogen-associated molecular patterns, including interferon γ (IFNγ), lipopolysaccharide (LPS), Pam3CSK4 (a synthetic bacterial lipopeptide), and muramyl dipeptide (MDP). Showed increased survival following intravenous delivery of TNF, a mouse model of systemic inflammation. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C19H27N3OS |
| Molecular Weight | 345.502 |
| Exact Mass | 345.187469 |
| LogP | 3.63 |
| Index of Refraction | 1.630 |